Floatz logo

1,128 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Ipilimumab
Non-Small Cell Lung Carcinoma
University of ChicagoP3BB (67)
Serplulimab
Non-Small Cell Lung Carcinoma
Tang-Du HospitalP2/3BB (67)
Acasunlimab
Non-Small Cell Lung Carcinoma
GenmabP3BB (66)
Adebrelimab
Non-Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP3BB (66)
Alectinib
Non-Small Cell Lung Carcinoma
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairP4BB (66)
Ateganosine
Non-Small Cell Lung Carcinoma
Maia BiotechnologyP3BB (66)
AZD9291
Non-Small Cell Lung Carcinoma
AstraZenecaP3BB (66)
Befotertinib
Non-Small Cell Lung Carcinoma
Hebei Medical University Fourth HospitalP3BB (66)
Crizotinib
Non-Small Cell Lung Carcinoma
Nuvation Bio Inc.P4BB (66)
Fruquintinib
Non-Small Cell Lung Carcinoma
Immunitas TherapeuticsP3BB (66)
Human Hyaluronidase Isozyme-5 (Hyal5, Sperm Adhesion Molecule 1, Spam1, Hyaluronidase Ph-20, Ec:3.2.1.35) Fragment (3-433, 1-431 In The Current Sequence) Engineered Variant With The Structural Domain Replaced By The Corresponding Region Of Human Hyaluronidase Isozyme-1 (Hyal1)(<Sup>306</Sup>Tlsimrsmkscllddnymeti<Sup>326</Sup>><Sup>304</Sup>Swentrtkescqaikeymdtt<Sup>324</Sup>), Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Dg44, Glycoform Alfa
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP3BB (66)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Non-Small Cell Lung Carcinoma
Sun Yat-sen UniversityP3BB (66)
Imp-321
Non-Small Cell Lung Carcinoma
Immutep S.A.S.P3BB (66)
Lorlatinib
Non-Small Cell Lung Carcinoma
Chugai PharmaceuticalP4BB (66)
Patritumab Deruxtecan
Non-Small Cell Lung Carcinoma
The Netherlands Cancer InstituteP3BB (66)
pf-08634404
Non-Small Cell Lung Carcinoma
PfizerP3BB (66)
sb27
Non-Small Cell Lung Carcinoma
Samsung Bioepis Co., Ltd.P3BB (66)
Tretinoin
Non-Small Cell Lung Carcinoma
Peking University People's HospitalP3BB (66)
Valaciclovir
Non-Small Cell Lung Carcinoma
Candel Therapeutics, Inc.P3BB (66)
Vibostolimab
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP3BB (66)
bay2927088
Non-Small Cell Lung Carcinoma
BayerP1/2BB (65)
Benmelstobart
Non-Small Cell Lung Carcinoma
The Third Xiangya Hospital of Central South UniversityP3BB (65)
Mobocertinib
Non-Small Cell Lung Carcinoma
TakedaP3BB (65)
Recombinant Human Egf-Rp64K
Non-Small Cell Lung Carcinoma
Roswell Park Cancer InstituteP2BB (65)
Rezivertinib
Non-Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical UniversityP3BB (65)
Sapanisertib
Non-Small Cell Lung Carcinoma
Faeth TherapeuticsP2BB (65)
Sargramostim
Non-Small Cell Lung Carcinoma
University of WashingtonP2BB (65)
Tirelizumab
Non-Small Cell Lung Carcinoma
Second Affiliated Hospital of Guangzhou Medical UniversityP2BB (65)
Belrestotug
Non-Small Cell Lung Carcinoma
GlaxoSmithKlineP3BB (64)
Capivasertib
Non-Small Cell Lung Carcinoma
Shanxi Province Cancer HospitalP2BB (64)
Danvatirsen
Non-Small Cell Lung Carcinoma
MedImmune LLCP2BB (64)
gme751
Non-Small Cell Lung Carcinoma
SandozP3BB (64)
hb0025
Non-Small Cell Lung Carcinoma
Shanghai Huaota Biopharmaceutical Co., Ltd.P3BB (64)
hlx17
Non-Small Cell Lung Carcinoma
Shanghai Henlius BiotechP3BB (64)
Nintedanib
Non-Small Cell Lung Carcinoma
Second Hospital of Shanxi Medical UniversityP3BB (64)
Recombinant Human Hyaluronidase
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P3BB (64)
Rivoceranib
Non-Small Cell Lung Carcinoma
The First Affiliated Hospital of Xiamen UniversityP4BB (64)
uv1
Non-Small Cell Lung Carcinoma
Vestre Viken Hospital TrustP2BB (64)
Volitinib
Non-Small Cell Lung Carcinoma
Qingdao Central HospitalP3BB (64)
Amivantamab-Vmjw
Non-Small Cell Lung Carcinoma
Janssen Research & Development, LLCP3B (63)
Catequentinib
Non-Small Cell Lung Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.P4B (63)
Datopotamab Deruxtecan
Non-Small Cell Lung Carcinoma
Memorial Sloan Kettering Cancer CenterP3B (63)
Divarasib
Non-Small Cell Lung Carcinoma
Hoffmann-La RocheP3B (63)
Ensartinib
Non-Small Cell Lung Carcinoma
Qiming WangP4B (63)
Immunoglobulin G1, Anti-(Human 5'-Nucleotidase) (Human Monoclonal Medi9447 Heavy Chain), Disulfide With Human Monoclonal Medi9447 .Lambda.-Chain, Dimer
Non-Small Cell Lung Carcinoma
Montefiore Medical CenterP3B (63)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Non-Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3B (63)
Olaparib
Non-Small Cell Lung Carcinoma
Qilu Pharmaceutical Co., Ltd.P3B (63)
Photofrin Ii
Non-Small Cell Lung Carcinoma
Roswell Park Cancer InstituteP1/2B (63)
Pumitamig
Non-Small Cell Lung Carcinoma
M.D. Anderson Cancer CenterP3B (63)
Rilvegostomig
Non-Small Cell Lung Carcinoma
AstraZenecaP3B (63)
Showing 51 to 100 of 1,128 assets
PreviousPage 2 of 23Next